首页> 外文OA文献 >Lipid–Polymer Hybrid Nanoparticle-Based Combination Treatment with Cisplatin and EGFR/HER2 Receptor-Targeting Afatinib to Enhance the Treatment of Nasopharyngeal Carcinoma

【2h】

Lipid–Polymer Hybrid Nanoparticle-Based Combination Treatment with Cisplatin and EGFR/HER2 Receptor-Targeting Afatinib to Enhance the Treatment of Nasopharyngeal Carcinoma

机译：基于脂质的杂交纳米粒子的基于联铂和EGFR / HER2受体 - 靶向AFATINIB的基于脂质的杂交纳米粒子的组合治疗，以增强鼻咽癌的治疗方法

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Dehui Fu; Chao Li; Yongwang Huang;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Elucidate the underlying molecular mechanisms of the combination treatment effects of Afatinib (EGFR/HER2 inhibitor) and Crizotinib (MET inhibitor) in cutaneous malignant melanoma (CMM) [J] . Das I., Chen H., Maddalo G., The Journal of investigative dermatology. . 2019,第9Suppla2期

机译：阐明AFATINIB（EGFR / HER2抑制剂）和CRIZOTINIB（MET抑制剂）在皮肤恶性黑色素瘤（CMM）中的组合治疗效果的潜在分子机制
2. Simultaneous Inhibition of EGFR and HER2 via Afatinib Augments the Radiosensitivity of Nasopharyngeal Carcinoma Cells [J] . Fangling Huang, Xujun Liang, Xiaoli Min, Journal of Cancer . 2019,第9期

机译：通过阿法替尼同时抑制EGFR和HER2增强了鼻咽癌细胞的放射敏感性
3. In vitro and in vivo efficacy of afatinib as a single agent or in combination with gemcitabine for the?treatment of nasopharyngeal carcinoma [J] . Cong Xue, Ying Tian, Jing Zhang, Drug Design, Development and Therapy . 2016,第5期

机译：阿法替尼单药或与吉西他滨联用治疗鼻咽癌的体外和体内疗效
4. Analysis of the Curative Effect of the Treatment of the Three-dimensional Conformal Radiotherapy Combination with the Induction Chemotherapy in the Middle-late Nasopharyngeal Carcinoma [C] . Min Ma, Hongying Lin, Shengcun Zhang International Forum on Bioinformatics and Medical Engineering . 2015

机译：三维保形放疗与中期鼻咽癌诱导化疗治疗疗效分析
5. The Use and Enhancement of Anti-Cancer Vaccine Therapy with Low-Toxicity Drugs for the Treatment of HER2 Positive Breast Cancer [D] . Oechsle, Crystal Mae 2019

机译：低毒药物抗癌疫苗治疗在HER2阳性乳腺癌治疗中的应用和增强
6. Lipid–Polymer Hybrid Nanoparticle-Based Combination Treatment with Cisplatin and EGFR/HER2 Receptor-Targeting Afatinib to Enhance the Treatment of Nasopharyngeal Carcinoma [O] . Dehui Fu, Chao Li, Yongwang Huang 2021

机译：基于脂质的杂交纳米粒子的基于联铂和EGFR / HER2受体 - 靶向AFATINIB的基于脂质的杂交纳米粒子的组合治疗以增强鼻咽癌的治疗方法
7. 489 Elucidate the underlying molecular mechanisms of the combination treatment effects of Afatinib (EGFR/HER2 inhibitor) and Crizotinib (MET inhibitor) in cutaneous malignant melanoma (CMM) [O] . I. Das, H. Chen, G. Maddalo, 2019

机译：489阐明在皮肤恶性黑色素瘤（CMM）中AMATINIB（EGFR / HER2抑制剂）和屈服（EMFR / HER2抑制剂）和屈服（MET抑制剂）的组合治疗效果的潜在分子机制

Lipid–Polymer Hybrid Nanoparticle-Based Combination Treatment with Cisplatin and EGFR/HER2 Receptor-Targeting Afatinib to Enhance the Treatment of Nasopharyngeal Carcinoma

著录项

引文网络

相似文献

相关主题

期刊订阅